Table 1.
Second level FunCat Enrichment Analysis* of genes differentially expressed.
| FunCat ID | Category | 15 min | 30 min | 1 h | 3 h | ||||
|---|---|---|---|---|---|---|---|---|---|
| Down hits (p-value) | Up hits (p-value) | Down hits (p-value) | Up hits (p-value) | Down hits (p-value) | Up hits (p-value) | Down hits (p-value) | Up hits (p-value) | ||
| 11.06 | RNA modification | 3 (6.56 × 10−3) | 3 (4.03 × 10−2) | 6 (7.10 × 10−3) | 3 (1.60 × 10−2) | ||||
| 11.04 | RNA processing | 6 (3.72 × 10−2) | 18 (3.51 × 10−4) | 25 (1.16 × 10−4) | 12 (1.18 × 10−4) | ||||
| 32.07 | Detoxification | 6 (3.10 × 10−2) | |||||||
| 02.13 | Respiration | 6 (9.29 × 10−3) | 11 (3.01 × 10−6) | ||||||
| 42.32 | Flagellum | 1 (1.17 × 10−2) | 1 (1.26 × 10−2) | ||||||
| 16.21 | Complex cofactor/cosubstrate/vitamine binding | 11 (1.72 × 10−2) | 14 (1.02 × 10−3) | ||||||
| 02.11 | Electron transport and membrane-associated energy conservation | 5 (2.18 × 10−2) | 9 (4.80 × 10−5) | ||||||
| 20.09 | Transport routes | 6 (2.90 × 10−2) | 10 (2.01 × 10−2) | 19 (3.61 × 10−2) | |||||
| 16.03 | Nucleic acid binding | 15 (4.29 × 10−2) | 3 (2.10 × 10−2) | 33 (3.14 × 10−3) | 13 (7.60 × 10−3) | ||||
| 16.25 | Oxygen binding | 1 (4.62 × 10−2) | 1 (4.95 × 10−2) | ||||||
| 01.05 | C-compound and carbohydrate metabolism | 12 (4.24 × 10−3) | 13 (2.20 × 10−6) | 18 (2.37 × 10−2) | |||||
| 20.01 | Transported compounds (substrates) | 12 (5.77 × 10−3) | 29 (1.13 × 10−3) | 24 (3.14 × 10−2) | |||||
| 01.01 | Amino acid metabolism | 17 (2.45 × 10−4) | |||||||
| 34.01 | Homeostasis | 9 (9.29 × 10−3) | |||||||
| 16.01 | Protein binding | 10 (1.49 × 10−2) | 54 (1.13 × 10−2) | 6 (3.09 × 10−2) | |||||
| 02.10 | Tricarboxylic-acid pathway | 3 (2.88 × 10−2) | |||||||
| 10.01 | DNA processing | 2 (3.05 × 10−2) | 28 (1.42 × 10−3) | ||||||
| 02.09 | Anaplerotic reactions | 1 (3.74 × 10−2) | |||||||
| 42.16 | Mitochondrion | 5 (4.11 × 10−2) | 4 (3.48 × 10−2) | ||||||
| 16.09 | Lipid binding | 3 (4.29 × 10−2) | |||||||
| 11.02 | RNA synthesis | 5 (4.76 × 10−2) | 2 (3.85 × 10−2) | ||||||
| 01.06 | Lipid, fatty acid and isoprenoid metabolism | 8 (2.13 × 10−3) | 1 (2.62 × 10−2) | ||||||
| 40.10 | Cell death | 10 (6.73 × 10−3) | |||||||
| 42.01 | Cell wall | 1 (1.51 × 10−2) | |||||||
| 12.07 | Translational control | 6 (1.98 × 10−2) | |||||||
| 16.17 | Metal binding | 27 (4.34 × 10−2) | |||||||
| 01.03 | Nucleotide/nucleoside/nucleobase metabolism | 9 (2.82 × 10−3) | |||||||
| 16.19 | Nucleotide/nucleoside/nucleobase binding | 14 (4.53 × 10−3) | |||||||
| 42.27 | Extracellular/secretion proteins | 2 (1.50 × 10−2) | |||||||
| 01.07 | Metabolism of vitamins, cofactors and prosthetic groups | 6 (4.58 × 10−2) | |||||||
*
p-value cutoff for enrichment analysis 0.05.